Eastman Chemical Co (EMN) is facing significant headwinds, evidenced by a 55.96% decline in EPS growth year-over-year and a 7.72% drop in revenue growth. The current price of $71.58 is well below the 52-week high of $83.47, indicating potential downside risk as the market capitalization stands at $8.19B with a P/E ratio of 20.55, which may be unattractive given its poor earnings growth. Investors should be cautious.
Given the deteriorating financial metrics, it is recommended to avoid Eastman Chemical Co stock at this time.
If Eastman can stabilize its earnings, the current dividend yield of 4.64% may attract income-focused investors. Additionally, the strong analyst consensus with 6 Strong Buy ratings could indicate potential for recovery if operational efficiencies improve.
The significant decline in EPS growth by 55.96% and revenue contraction of 7.72% highlight fundamental weaknesses that could persist in the near term. Moreover, with the current price trailing the 52-week high by 14.26%, there remains substantial downside risk.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates EMN as Bearish. Given the deteriorating financial metrics, it is recommended to avoid Eastman Chemical Co stock at this time.
The significant decline in EPS growth by 55.96% and revenue contraction of 7.72% highlight fundamental weaknesses that could persist in the near term. Moreover, with the current price trailing the 52-week high by 14.26%, there remains substantial downside risk.
If Eastman can stabilize its earnings, the current dividend yield of 4.64% may attract income-focused investors. Additionally, the strong analyst consensus with 6 Strong Buy ratings could indicate potential for recovery if operational efficiencies improve.
Eastman Chemical Co (EMN) is facing significant headwinds, evidenced by a 55.96% decline in EPS growth year-over-year and a 7.72% drop in revenue growth. The current price of $71.58 is well below the 52-week high of $83.47, indicating potential downside risk as the market capitalization stands at $8.19B with a P/E ratio of 20.55, which may be unattractive given its poor earnings growth. Investors should be cautious.
Eastman Chemical Co (EMN) is facing significant headwinds, evidenced by a 55.96% decline in EPS growth year-over-year and a 7.72% drop in revenue growth. The current price of $71.58 is well below the 52-week high of $83.47, indicating potential downside risk as the market capitalization stands at $8.19B with a P/E ratio of 20.55, which may be unattractive given its poor earnings growth. Investors should be cautious. Our overall verdict is Bearish.
Helm Terminal offers free AI-powered stock analysis for EMN at helmterminal.dev/analyze/EMN, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.